Real-time enrollment status for this non-squamous, non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:20 AM UTC
| NCT Number | NCT07660094 |
| Recruiting Status | Recruiting |
| Condition | Non-squamous, Non-Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 500 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Candel Therapeutics, Inc. |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT07660094 is currently recruiting participants. This phase3 study for non-squamous, non-small cell lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Candel Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07660094 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07660094 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.